Last reviewed · How we verify
Isoamyl Methoxycinnamate (AMILOXATE)
Isoamyl Methoxycinnamate (generic name: AMILOXATE) is a amiloxate drug. It is currently FDA-approved.
Isoamyl Methoxycinnamate is a small molecule used as a sunscreen filter. It has been studied in clinical trials for conditions such as dermatitis and photocontact.
At a glance
| Generic name | AMILOXATE |
|---|---|
| Drug class | amiloxate |
| Modality | Small molecule |
| Therapeutic area | Oncology |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Isoamyl Methoxycinnamate CI brief — competitive landscape report
- Isoamyl Methoxycinnamate updates RSS · CI watch RSS
Frequently asked questions about Isoamyl Methoxycinnamate
What is Isoamyl Methoxycinnamate?
Isoamyl Methoxycinnamate (AMILOXATE) is a amiloxate drug.
What is the generic name of Isoamyl Methoxycinnamate?
AMILOXATE is the generic (nonproprietary) name of Isoamyl Methoxycinnamate.
What drug class is Isoamyl Methoxycinnamate in?
Isoamyl Methoxycinnamate belongs to the amiloxate class. See all amiloxate drugs at /class/amiloxate.
What development phase is Isoamyl Methoxycinnamate in?
Isoamyl Methoxycinnamate is FDA-approved (marketed).
Related
- Drug class: All amiloxate drugs
- Therapeutic area: All drugs in Oncology
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing